Immunoglobulins and complement deposits in Mitroflow pericardial bioprosthetic heart valves - A contributing factor to structural deterioration

Journal of Heart Valve Disease

Volumn 5, Issue SUPPL. 3, 1996, Pages

  Moczar, Madeleine ^a,b   Lecerf, Laure ^a   Mazzucotelli, Jean Philippe ^a   Loisance, Daniel ^a  

^a CNRS   (France)

^b FACULTÉ DE MÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; FIBRONECTIN; IMMUNOGLOBULIN;

ADULT; AGED; CALCIFICATION; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HEART VALVE BIOPROSTHESIS; HEART VALVE REGURGITATION; HISTOLOGY; HUMAN; MALE; PHAGOCYTOSIS; PRIORITY JOURNAL; ULTRASTRUCTURE;

AGED; BIOPROSTHESIS; EQUIPMENT FAILURE ANALYSIS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; RISK FACTORS;

EID: 0029852647     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Mazzucotelli JP, Bertrand PC, Loisance DY. The Mitroflow pericardial valve clinical performance to 10 years. J Heart Valve Dis 1995;4:407-413
2. Trowbridge EA, Lawford PV, Crofts CE, Roberts KM. Pericardial heterografts: why do these valves fail? J Thorac Cardiovasc Surg 1988;95:577-585
3. Schoen FJ, Femandez J, Gonzalez-Lavin L, Cernaianu A. Causes of failure and pathologic findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bioprostheses: emphasis on progressive structural deterioration. Circulation 1987;76:618-627
4. Walley VM, Rubens FD, Campagna H, Pipe AL, Keon WJ. Pattern of failure in Hancock pericardial bioprostheses. J Thorac Cardiovasc Surg 1991;102:187-194
5. Walley VM, Keon W. Failure of Hancock pericardial bioprostheses. J Heart Valve Dis 1994;3:585
6. Vetter HO, Krupa W, Nerlich A, et al. New morphologic aspects of explanted Hancock extracorporeal pericardial bioprostheses. J Heart Valve Dis 1994;3:335-342
7. Lèandri J, Bertrand P, Mazzucotelli JP, Loisance D. Mode of failure of the Mitroflow pericardial valve. J Heart Valve Dis 1992;1:226-231
8. Gabbay S, Bortolotti U, Wasserman F, Factor S, Strom J, Frater RWM. Fatigue induced failure of the Ionescu-Shiley pericardial xenografts in mitral position. In vivo and in vitro correlation and proposed classification. Thorac Cardiovasc Surg 1984;87:836-844
9. Gabbay S, Kadam P, Factor S, Cheng TK. Do heart valve bioprostheses degenerate for metabolic or mechanical reasons. J Thorac Cardiovasc Surg 1988;95:208-215
10. Ferrans VJ, Spray TL, Billingham ME, Roberts VC. Structural changes in glutaraldehyde treated porcine heterografts used as substitute cardiac valves. Am J Cardiol 1978;41:1159-1183
11. Ishihara T, Ferrans VJ, Boyce SW, Jones M, Roberts VC. Structure and classification of cuspal tears and perforations in porcine bioprosthetic cardiac valves. Am J Cardiol 1981;48:665-678
12. Bemacca GM, Mackay T, Wheatley D. In vitro calcification of bioprosthetic heart valves: report of a novel method and review of the biochemical factors involved. J Heart Valve Dis 1992;1:115-130
13. Grabenwöger M, Grimm M, Eybl E, et al. New aspect of the degeneration of bioprosthetic heart valves after long-term implantation. J Thorac Cardiovasc Surg 1992;104:14-21
14. Shen LL, Donagh RP, Donagh J, Hermans J. Early events in the plasmin digestion of fibrinogen and fibrin. J Biol Chem 1977;252:6184-6189
15. Ciernievski C, Plow EF, Edgington TS. An immunochemical homology between the Aα and the DE complex-depent site of the γ chain of the fibrinogen. J Biol Chem 1977,252:8917-8923
16. Griesmacher A, Losert V, Böck P, et al. Biocompatibility of aldehyde-fixed bovine pericardium. J Thorac Cardiovasc Surg 1991;102:195-201
17. Moczar M, Mazzucotelli JP, Bertrand P, Ginat M, Léandri J, Loisance D. Deterioration of bioprosthetic heart valves. ASAIO Journal 1994;40:M697-M701
18. He C, Wilhelm SM, Pentland AP, et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Nat Acad Sci US 1989;86:2632-2636
19. Furie MB, Rifkin DB. Proteolytically derived fragments of human plasma fibronectin and their localization within the intact molecule. J Biol Chem 1980;255:3134-3140
20. Roitt I, Brostoff J, Male D. Complement. In: Immunology. 2nd ed. London, New York, Grower, 1989:13.1-13.16
21. Rent R, Ertel N, Eisenstein R, Gewürz H. Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement. J Immunol 1975;114:120-124
22. Kaplan AP, Silverberg M, Dunn JT, Ghebrehiwet B. Interaction of clotting, kinin-forming, complement and fibrinolytic pathways in inflammation. Ann N.Y. Acad Sci 1982:25-38
23. Ghebrehiwet B, Randazzo BP, Dunn JT, Silverberg M, Kaplan AP. Mechanisms of the activation of classical pathway of complement by Hageman factor fragment. J Clin Invest 1983;71:1450-1456
24. Dahm M, Lyman WD, Schwell AB, Factor SM, Frater RW. Immunogenicity of glutaraldehyde tanned bovine pericardium. J Thorac Cardiovasc Surg 1990;99:1082-1090
25. Gong G, Seifter E, Lyman WD, Factor SM, Blau S, Frater RWM. Bioprosthetic cardiac valve degeneration: role of inflammatory and immune reaction. J Heart Valve Dis 1993;2:684-693
26. Norris DA, Clark RAF, Swigart LM, Herff JC, Weston WL, Howell SE. Fibronectin fragments are chemotactic for human peripheral blood monocytes. J Immunol 1982;129:1612-1618
27. Shah PK, Falk E, Badimon JJ, et al. Human monocyte derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995;95:1565-1569
28. Colvin RB, Dvorak HF. Fibrinogen/fibrin on the surface of macrophages detection, distribution, binding requirements and possible role in macrophage adherence phenomena. J Exp Med 1975,142:1377-1390
29. Craddock PR, Hammerschmidt D, White JG, Dalmasso AP, Jacob HS. Complement (C5a) induced granulocyte aggregation in vitro. J Clin Invest 1977,60:260-264
30. 2-plasmin inhibitor complexes during cardiopulmonary bypass. Blood 1989,73:468-471